Rigel Pharmaceuticals RIGL Right-of-use assets
Right-of-use assets at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept rigl:IncreaseDecreaseRightOfUseAssets.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's right-of-use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's right-of-use assets?
- Rigel Pharmaceuticals (RIGL) reported right-of-use assets of $135K in Q1 2026.
- How has Rigel Pharmaceuticals's right-of-use assets changed year-over-year?
- Rigel Pharmaceuticals's right-of-use assets increased by 112.7% year-over-year, from -$1.06M to $135K.
- What is the long-term trend for Rigel Pharmaceuticals's right-of-use assets?
- Over 3 years (2021 to 2024), Rigel Pharmaceuticals's right-of-use assets has grown at a -57.8% compound annual growth rate (CAGR), from $8.19M to $615K.
- What does right-of-use assets mean?
- Captures the net change in the carrying value of right-of-use assets arising from operating lease arrangements. This metric reflects the non-cash impact of lease accounting standards on the company's balance sheet and operational cash flow reconciliations. It provides insight into the company's commitment to leased facilities or equipment.